About Bevatas 100mg Injection
Bevatas 100mg Injection contains Bevacizumab, a targeted anticancer medication used in combination with chemotherapy to treat various types of cancer, including metastatic breast cancer, colorectal cancer, lung cancer, kidney cancer, cervical cancer, brain cancer, and certain gynecological cancers such as ovarian, fallopian tube, and primary peritoneal cancer. It works by blocking the formation of new blood vessels that tumors need to grow and spread, helping to slow cancer progression. Women of childbearing age should use effective contraception during treatment and for at least six months after the last dose, as Bevacizumab may harm an unborn baby and can potentially affect fertility. Breastfeeding is not recommended during treatment due to possible risks to infant growth and development. Common side effects of Bevatas 100mg Injection include constipation, decreased appetite, runny nose, fever, skin-related reactions, and weight loss. Patients should inform their doctor about any history of high blood pressure, diabetes, heart disease, stomach disorders, or planned surgical procedures before starting treatment. Because this medicine may impair wound healing and increase the risk of bleeding, it is generally not recommended within 28 days before or after surgery. Patients should also report any dental problems requiring surgery, vision changes, severe headaches, or confusion, as these symptoms may indicate serious complications that require immediate medical attention. Regular monitoring by a healthcare professional helps ensure the safe and effective use of Bevatas 100mg Injection during cancer treatment.
Trusted Therapeutic for Brain CancerBevatas 100mg Injection is recognized for its crucial role in treating glioblastoma multiforme. The formulation, based on Bevacizumab, targets cancer progression and supports patient care in specialized medical settings. Indian manufacturers supply this reliable treatment option globally, ensuring stringent standards.
Proper Storage and HandlingThis liquid medication requires refrigeration within a strict temperature range of 2-8C to maintain its efficacy. Healthcare professionals and suppliers should ensure consistent cooling during storage and transit, which preserves the quality and safety of Bevatas 100mg Injection for patients.
FAQ's of Bevatas 100mg Injection:
Q: How should Bevatas 100mg Injection be stored?
A: Bevatas 100mg Injection must be stored at a controlled temperature between 2C and 8C. Proper refrigeration is essential to retain the medication's potency and ensure its safe administration.
Q: What condition does Bevatas 100mg Injection treat?
A: This medication is indicated for the treatment of glioblastoma multiforme, an aggressive form of brain cancer. Its active ingredient, Bevacizumab, helps inhibit the growth of cancerous cells.
Q: When is Bevatas 100mg Injection administered during treatment?
A: Bevatas 100mg Injection is given as part of a comprehensive cancer treatment plan and is usually administered under the supervision of a healthcare professional in a clinical setting.
Q: Where does Bevatas 100mg Injection originate from?
A: The injection is manufactured, exported, and supplied from India, known for its robust pharmaceutical production standards and reliable distribution network.
Q: What is the benefit of using Bevatas 100mg Injection in glioblastoma management?
A: Bevatas 100mg Injection, containing Bevacizumab, can help slow the progression of glioblastoma multiforme, potentially improving outcomes and quality of life for patients when used alongside other therapies.
Q: How is Bevatas 100mg Injection supplied and packaged?
A: The product is typically supplied in a single-dose vial per box, ensuring accurate dosing and ease of administration for healthcare professionals.
Q: What is the process of administering Bevatas 100mg Injection?
A: The injection is administered intravenously by a qualified healthcare provider, following a prescribed regimen tailored to the individual needs of the patient and based on medical assessment.